TCL Archive In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform May 9, 1997
TCL Archive In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35% October 14, 1977
TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
